The immune system, depression and the action of antidepressants

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 25, Issue 4, 2001, Pages 767-780

  Leonard, B E ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Biogenic amines; Cytokines; Depression; Glucocorticoids; Prostaglandins; Sickness behaviour

Indexed keywords

ACUTE PHASE PROTEIN; ANTIDEPRESSANT AGENT; CYTOKINE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 1 RECEPTOR; PROSTAGLANDIN;

CELLULAR IMMUNITY; DEPRESSION; HORMONE RELEASE; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; MACROPHAGE; NATURAL KILLER CELL; NEUROTRANSMISSION; NORADRENERGIC SYSTEM; REVIEW; SEROTONINERGIC SYSTEM; T LYMPHOCYTE;

EID: 0035035367     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(01)00155-5     Document Type: Article

References (50)

1. Immune-neuroendocrine interactions: Facts and hypotheses
2. Central injection of IL-10 antagonises the behavioural effects of lipopolysaccharide in rats
3. Synergistic effects of interleukin-1 beta, interleukin-6 and tumour necrosis factor-alpha: Central monoamine, corticosterone and behavioral variations
4. Attentional and mnemonic deficits associated with infectious diseases in humans
5. The effect of oestrogen and progesterone on uterine prostaglandin synthesis in the ovariectomized rat
6. Depression, immunocompetence and prostaglandins of the E series
7. Stressor-induced alterations in serotonergic activity in an animal model of depression
8. Olfactory bulbectomy provokes a suppression of interleukin- 1 beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: Effect of chronic desipramine treatment
9. Type 2 (glucocorticoid) receptors mediate fast feedback inhibition of the hypothalamic-pituitary-adrenal axis in man
10. Interleukin-1 receptors in the brain and endocrine tissue
11. Molecular basis of sickness behavior
12. Immunological effects of neuropsychiatric substances
13. Effect of anti-PGE antibody on cell mediated immune response in thermally induced mice
14. Surface contact modulation of inflammatory macrophage antibody dependent cytotoxicity and prostanoid release
15. Biological basis of the behavior of sick animals
16. Are cytokines associated with neuropsychiatric syndromes in humans?
17. Effects of antidepressants on weight and on plasma levels of leptin. TNF-alpha and soluble TNF receptors: A longitudinal study in patients treated with amitriptyline or paroxetine
18. Antidepressants and hypothalamic-pituitary-adrenocortical regulation
19. The role of prostaglandins and prolactin in depression, mania and schizophrenia
20. Effect of chronic treatment with imipramine on IL-1 and IL-2 production by splenocytes obtained from rats subjected to chronic mild stress model of depression
21. Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-gamma and interleukin-10
22. Brain cytokines and the psychopathology of depression
23. Elevated levels of prostaglandin E2 and thromboxane B2 in depression
24. Regulation of nitric oxide synthase messenger RNA expression in the rat hippocampus by glucocorticoids
25. Neutrophil and monocyte phagocytosis in depressed patients
26. The monocyte and T-lymphocyte hypothesis of major depression
27. Fatty acid composition in major depression: Decreased omega 3 fractions in cholesteryl esters and increased C20:4w6/C20:5w43 ratio in cholestryl esters and phospholipids
28. Immune and clinical correlates of psychological stress-induced production of interferon-gamma and IL-10 in humans
29. Cytokines for psychologists: Implications of bidirectional immune to brain communication for understanding behavior, mood and cognition
30. Increased biogenic amine release in mouse hypothalamus following immunological challenge: Antagonism by in domethacin
31. Actions of the tricyclic antidepressant clomipramine on responses to pressor agents: Interactions with prostaglandin E2
32. Abnormal zymosan-induced neutrophil chemiluminescence as a marker of depression
33. The pathophysiologic roles of interleukin-6 in human disease
34. Regulation of the human serotonin transporter by interleukin-1 beta
35. In the rat, interleukin-1 alpha and beta stimulate adrenocorticotropin and catecholamine release
36. Cytokines and the nervous system: Actions and mechanisms
37. Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat
38. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine
39. The macrophage theory of depression
40. The effects of olfactory bulbectomy in the rat, alone and in combination with antidepressants and endogenous factors, on immune function
41. Changes in immunoglobulin, complement and acute phase protein concentrations in depressed patients and normal controls
42. The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression
43. Induction of interleukin-1 beta and interleukin-1 receptor antagonist mRNA by chronic treatment with various psychotropics is widespread areas of rat brain
44. Regulation of the HPA axis by cytokines
45. Effects of psychotropic drugs on the behaviour and neurochemistry of olfactory bulbectomised rats
46. TCA's inhibit IL-1, IL-6 and TNF release in human blood monocytes and IL-2 and interferon in T-cells
47. Endotoxin produces a depressive-like episode in rats